Randolf J. Kerschbaumer
Vienna, 1030, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Integrating In Silico and In Vitro Tools for Optimized Antibody Development-Design of Therapeutic Anti-oxMIF Antibodies.
Journal: Antibodies (Basel, Switzerland)
Published: November 12, 2024
Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis.
Journal: PloS one
Published: May 24, 2024
Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer.
Journal: Molecular cancer therapeutics
Published: February 01, 2024
The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis.
Journal: European journal of pharmacology
Published: May 08, 2023
Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic.
Journal: Molecular cancer therapeutics
Published: October 18, 2022
Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics.
Journal: Antibodies (Basel, Switzerland)
Published: July 23, 2019
Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis.
Journal: European journal of pharmacology
Published: October 17, 2017
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 11, 2015
Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo.
Journal: Molecular cancer therapeutics
Published: April 27, 2013
Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF.
Journal: The Journal of biological chemistry
Published: January 13, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026